Author:
Dana Hassan, ,Chalbatani Ghanbar Mahmoodi,Mahmoodzadeh Habibollah,Gharagouzlo Elahe,Karimloo Rezvan,Rezaiean Omid,Moradzadeh Amirreza,Mazraeh Ali,Marmari Vahid,Rashno Mohammad Menati,Mehmandoost Narges,Moazzen Fateme,Ebrahimi Mohammad,Abadi Saeid Jan, , , , , , ,
Abstract
One of the most important advances in biology has been the discovery that siRNA (small interfering RNA) is able to regulate the expression of genes, by a phenomenon known as RNAi (RNA interference). The discovery of RNAi, first in plants and Caenorhabditis elegans and later in mammalian cells, led to the emergence of a transformative view in biomedical research. siRNA has gained attention as a potential therapeutic reagent due to its ability to inhibit specific genes in many genetic diseases. siRNAs can be used as tools to study single gene function both in vivo and in-vitro and are an attractive new class of therapeutics, especially against undruggable targets for the treatment of cancer and other diseases. The siRNA delivery systems are categorized as non-viral and viral delivery systems. The non-viral delivery system includes polymers; Lipids; peptides etc. are the widely studied delivery systems for siRNA. Effective pharmacological use of siRNA requires ‘carriers’ that can deliver the siRNA to its intended site of action. The carriers assemble the siRNA into supramolecular complexes that display functional properties during the delivery process.
Publisher
International Assotiation of Biomedical Sciences
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Cited by
118 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献